CS logo
small CS logo
Wrightington, Wigan and Leigh NHS Foundation Trust

Wigan, United Kingdom

About Wrightington, Wigan and Leigh NHS Foundation Trust


Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust is an NHS Foundation Trust providing services in the Metropolitan Borough of Wigan and Wrightington, England.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Wrightington, Wigan and Leigh NHS Foundation Trust


During the past decade, Wrightington, Wigan and Leigh NHS Foundation Trust conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Wrightington, Wigan and Leigh NHS Foundation Trust" #1 sponsor was "Wrightington, Wigan and Leigh NHS Foundation Trust" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Limacorporate S.p.a" with 1 trials sponsored, "Manchester University NHS Foundation Trust" with 1 trials sponsored and "Optinose US Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Wrightington, Wigan and Leigh NHS Foundation Trust" #1 collaborator was "Edge Hill University" with 2 trials as a collaborator, "Abbott Point of Care" with 1 trials as a collaborator, "LumiraDx" with 1 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 1 trials as a collaborator and "Roche Diagnostics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

Clinical Trials Conditions at Wrightington, Wigan and Leigh NHS Foundation Trust


According to Clinical.Site data, the most researched conditions in "Wrightington, Wigan and Leigh NHS Foundation Trust" are "Chronic Rhinosinusitis" (3 trials), "Nasal Polyps" (2 trials), "Acute Coronary Syndrome" (1 trials), "Anterior Cruciate Ligament Injury" (1 trials) and "Arthroplasty, Replacement, Shoulder" (1 trials). Many other conditions were trialed in "Wrightington, Wigan and Leigh NHS Foundation Trust" in a lesser frequency.

Clinical Trials Intervention Types at Wrightington, Wigan and Leigh NHS Foundation Trust


Most popular intervention types in "Wrightington, Wigan and Leigh NHS Foundation Trust" are "Drug" (4 trials), "Procedure" (4 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Omalizumab" (2 trials), "Placebo" (2 trials), "Axillary lymph node dissection" (1 trials), "Axillary radiotherapy" (1 trials) and "Breast or chest wall radiotherapy" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Wrightington, Wigan and Leigh NHS Foundation Trust


The vast majority of trials in "Wrightington, Wigan and Leigh NHS Foundation Trust" are 13 trials for "All" genders.

Clinical Trials Status at Wrightington, Wigan and Leigh NHS Foundation Trust


Currently, there are NaN active trials in "Wrightington, Wigan and Leigh NHS Foundation Trust". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Wrightington, Wigan and Leigh NHS Foundation Trust, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Wrightington, Wigan and Leigh NHS Foundation Trust, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".